161 related articles for article (PubMed ID: 8850464)
21. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma.
Ris HB; Altermatt HJ; Nachbur B; Stewart JC; Wang Q; Lim CK; Bonnett R; Althaus U
Int J Cancer; 1993 Jan; 53(1):141-6. PubMed ID: 8416199
[TBL] [Abstract][Full Text] [Related]
22. Optimizing meso-tetra-hydroxyphenyl-chlorin-mediated photodynamic therapy for basal cell carcinoma.
Triesscheijn M; Ruevekamp M; Antonini N; Neering H; Stewart FA; Baas P
Photochem Photobiol; 2006; 82(6):1686-90. PubMed ID: 16984216
[TBL] [Abstract][Full Text] [Related]
23. Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves.
Kübler AC; Stenzel W; Rühling M; Meul B; Fischer JH
Lasers Surg Med; 2003; 33(4):247-55. PubMed ID: 14571449
[TBL] [Abstract][Full Text] [Related]
24. mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells.
Reidy K; Campanile C; Muff R; Born W; Fuchs B
Photochem Photobiol; 2012; 88(3):721-7. PubMed ID: 22268498
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum cytokine levels in mesothelioma patients who have undergone pleurectomy or extrapleural pneumonectomy and adjuvant intraoperative photodynamic therapy.
Yom SS; Busch TM; Friedberg JS; Wileyto EP; Smith D; Glatstein E; Hahn SM
Photochem Photobiol; 2003 Jul; 78(1):75-81. PubMed ID: 12929752
[TBL] [Abstract][Full Text] [Related]
26. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.
Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG
Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593
[TBL] [Abstract][Full Text] [Related]
27. Endobronchial photodynamic therapy: comparison of mTHPC and polyethylene glycol-derived mTHPC on human tumor xenografts and tumor-free bronchi of minipigs.
Ris HB; Im Hof V; Stewart CM; Mettler D; Altermatt HJ
Lasers Surg Med; 1998; 23(1):25-32. PubMed ID: 9694147
[TBL] [Abstract][Full Text] [Related]
28. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.
Friedberg JS; Mick R; Stevenson J; Metz J; Zhu T; Buyske J; Sterman DH; Pass HI; Glatstein E; Hahn SM
Ann Thorac Surg; 2003 Mar; 75(3):952-9. PubMed ID: 12645723
[TBL] [Abstract][Full Text] [Related]
29. Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulval intraepithelial neoplasia.
Campbell SM; Gould DJ; Salter L; Clifford T; Curnow A
Br J Dermatol; 2004 Nov; 151(5):1076-80. PubMed ID: 15541088
[TBL] [Abstract][Full Text] [Related]
30. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
31. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer.
Mang TS; Allison R; Hewson G; Snider W; Moskowitz R
Cancer J Sci Am; 1998; 4(6):378-84. PubMed ID: 9853137
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience.
Ell C; Gossner L; May A; Schneider HT; Hahn EG; Stolte M; Sroka R
Gut; 1998 Sep; 43(3):345-9. PubMed ID: 9863479
[TBL] [Abstract][Full Text] [Related]
33. Optimization of treatment parameters for Foscan-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2008 Jul; 40(5):300-11. PubMed ID: 18563776
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G
Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244
[TBL] [Abstract][Full Text] [Related]
35. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
[TBL] [Abstract][Full Text] [Related]
36. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
Mikvy P; Messman H; MacRobert AJ; Pauer M; Sams VR; Davies CL; Stewart JC; Bown SG
Br J Cancer; 1997; 76(6):713-8. PubMed ID: 9310235
[TBL] [Abstract][Full Text] [Related]
38. The use of photodynamic therapy as adjuvant therapy to surgery in recurrent malignant tumors of the paranasal sinuses.
Caesar L; van Doeveren TE; Tan IB; Dilci A; van Veen RL; Karakullukcu B
Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):414-21. PubMed ID: 26072296
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy for cholangiocarcinoma using low dose mTHPC (Foscan(®)).
Kniebühler G; Pongratz T; Betz CS; Göke B; Sroka R; Stepp H; Schirra J
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):220-8. PubMed ID: 23993847
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant intraoperative photodynamic therapy in experimental colorectal cancer using a new photosensitizer.
Abulafi AM; DeJode ML; Allardice JT; Ansell JK; Williams NS
Br J Surg; 1997 Mar; 84(3):368-71. PubMed ID: 9117310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
